Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research, vol.4, issue.Suppl 1, pp.244-249, 2006. ,
DOI : 10.1248/bpb1978.4.879
A physicochemical study of the morphology of progesterone-loaded poly (d,l-lactide) microspheres, International Journal of Pharmaceutics, vol.29, issue.2-3, pp.95-102, 1986. ,
DOI : 10.1016/0378-5173(86)90106-7
Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen, Journal of Controlled Release, vol.10, issue.2, pp.167-175, 1989. ,
DOI : 10.1016/0168-3659(89)90059-X
Solvent selection in the preparation of poly, 1988. ,
Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery, International Journal of Pharmaceutics, vol.116, issue.1, pp.1-9, 1995. ,
DOI : 10.1016/0378-5173(94)00324-X
Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system, International Journal of Pharmaceutics, vol.342, issue.1-2, pp.72-77, 2007. ,
DOI : 10.1016/j.ijpharm.2007.04.034
Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs, American Journal of Veterinary Research, vol.65, issue.6, pp.752-757, 2004. ,
DOI : 10.2460/ajvr.2004.65.752
Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials, vol.21, issue.16, pp.1659-1668, 2000. ,
DOI : 10.1016/S0142-9612(00)00040-5
Controlled release from bioerodible polymers: effect of drug type and polymer composition, Journal of Controlled Release, vol.102, issue.2, pp.333-344, 2005. ,
DOI : 10.1016/j.jconrel.2004.10.019
Polymer microspheres for controlled drug release, International Journal of Pharmaceutics, vol.282, issue.1-2, pp.1-18, 2004. ,
DOI : 10.1016/j.ijpharm.2004.04.013
Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs, Veterinary Parasitology, vol.135, issue.3-4, 2006. ,
DOI : 10.1016/j.vetpar.2005.10.002
The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009. ,
DOI : 10.1016/j.tvjl.2007.07.011
Effect of the microencapsulation of nanoparticles on the reduction of burst release, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.53-61, 2007. ,
DOI : 10.1016/j.ijpharm.2007.05.066
Characterization of biodegradable poly(d,l-lactide-co-glycolide) polymers and microspheres, Journal of Pharmaceutical and Biomedical Analysis, vol.13, issue.6, pp.747-760, 1995. ,
DOI : 10.1016/0731-7085(95)01276-Q
Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds, Veterinary Parasitology, vol.72, issue.3-4, pp.367-382, 1997. ,
DOI : 10.1016/S0304-4017(97)00106-4
The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method, Journal of Controlled Release, vol.36, issue.1-2, pp.63-71, 1995. ,
DOI : 10.1016/0168-3659(95)00051-9
Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles, Journal of Microencapsulation, vol.19, issue.2, pp.117-128, 2007. ,
DOI : 10.1023/A:1015168301339
The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix, International Journal of Pharmaceutics, vol.201, issue.1, pp.29-36, 2000. ,
DOI : 10.1016/S0378-5173(00)00388-4
How porosity and size affect the drug release mechanisms from PLGA-based microparticles, International Journal of Pharmaceutics, vol.314, issue.2, pp.198-206, 2006. ,
DOI : 10.1016/j.ijpharm.2005.07.031
The influence of solvent composition on the specific viscosities of polymer solutions, Journal of Colloid Science, vol.2, issue.1, pp.99-114, 1947. ,
DOI : 10.1016/0095-8522(47)90013-5
Biodegradation and biocompatibility of PLA and PLGA microspheres, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.5-24, 1997. ,
DOI : 10.1016/S0169-409X(97)00048-3
Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.62, issue.3, pp.333-344, 1999. ,
DOI : 10.1016/S0168-3659(99)00159-5
An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots, Journal of Controlled Release, vol.122, issue.1, pp.79-85, 2007. ,
DOI : 10.1016/j.jconrel.2007.06.013
Stability of poly(d,l-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems, Journal of Controlled Release, vol.115, issue.2, pp.158-167, 2006. ,
DOI : 10.1016/j.jconrel.2006.07.013
Biodegradable in-situ forming implants and methods of producing the same, p.763, 1990. ,
Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs, Veterinary Parasitology, vol.135, issue.3-4, 2006. ,
DOI : 10.1016/j.vetpar.2005.10.002
The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009. ,
DOI : 10.1016/j.tvjl.2007.07.011
Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.58, issue.2, pp.233-245, 1999. ,
DOI : 10.1016/S0168-3659(98)00158-8
The three dimensional solubility parameter-key to paint component affinities: II and III, J. Paint Technol, vol.39, pp.505-514, 1967. ,
Hansen solubility parameters, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01639526
Biodegradable injectable in situ forming drug delivery systems, Journal of Controlled Release, vol.80, issue.1-3, 2002. ,
DOI : 10.1016/S0168-3659(02)00008-1
The Viscosity of Dilute Solutions of Long-Chain Molecules. IV. Dependence on Concentration, Journal of the American Chemical Society, vol.64, issue.11, pp.2716-2718, 1942. ,
DOI : 10.1021/ja01263a056
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, vol.21, issue.23, pp.2475-2490, 2000. ,
DOI : 10.1016/S0142-9612(00)00115-0
Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process, Journal of Controlled Release, vol.130, issue.3, pp.220-225, 2008. ,
DOI : 10.1016/j.jconrel.2008.06.006
Development of an in situ forming PLGA drug delivery system, European Journal of Pharmaceutical Sciences, vol.35, issue.4, pp.283-292, 2008. ,
DOI : 10.1016/j.ejps.2008.07.007
Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008. ,
DOI : 10.1016/j.ejps.2008.03.004
Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins, Journal of Controlled Release, vol.33, issue.1, pp.189-195, 1995. ,
DOI : 10.1016/0168-3659(94)00083-7
Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research, vol.4, issue.Suppl 1, pp.244-249, 2006. ,
DOI : 10.1248/bpb1978.4.879
Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.62, issue.3, pp.333-344, 1999. ,
DOI : 10.1016/S0168-3659(99)00159-5
Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables Journal of microencapsulation, 2010. ,
Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs, American Journal of Veterinary Research, vol.65, issue.6, pp.752-757, 2004. ,
DOI : 10.2460/ajvr.2004.65.752
Mdr1: Quand la génétique s'en mêle, 2010. ,
Comparative evaluation of acute toxicity of ivermectin by two methods after single subcutaneous administration in rats, Regulatory Toxicology and Pharmacology, vol.47, issue.3, pp.257-260, 2007. ,
DOI : 10.1016/j.yrtph.2006.10.009
Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent, Journal of Pharmaceutical and Biomedical Analysis, vol.8, issue.6, pp.507-511, 1990. ,
DOI : 10.1016/0731-7085(90)80060-3
Biodegradable in-situ forming implants and methods of producing the same, US Patent, vol.4, p.938763, 1990. ,
Ivermectin: does P-glycoprotein play a role in neurotoxicity?, Filaria Journal, pp.1-6, 2003. ,
The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009. ,
DOI : 10.1016/j.tvjl.2007.07.011
Effect of the microencapsulation of nanoparticles on the reduction of burst release, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.53-61, 2007. ,
DOI : 10.1016/j.ijpharm.2007.05.066
Biodegradable injectable in situ forming drug delivery systems, Journal of Controlled Release, vol.80, issue.1-3, 2002. ,
DOI : 10.1016/S0168-3659(02)00008-1
Dissertation: In vitro and in vivo properties of injectable biodegradable in situ forming microparticle systmes, Faculty of Biology, 2002. ,
A novel in situ forming drug delivery system for controlled parenteral drug delivery, International Journal of Pharmaceutics, vol.332, issue.1-2, pp.107-114, 2007. ,
DOI : 10.1016/j.ijpharm.2006.09.033
Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008. ,
DOI : 10.1016/j.ejps.2008.03.004
Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle, Veterinary Parasitology, vol.86, issue.3, pp.203-215, 1999. ,
DOI : 10.1016/S0304-4017(99)00142-9
Microspheres of corn protein, zein, for an ivermectin drug delivery system, Biomaterials, vol.26, issue.1, pp.109-115, 2005. ,
DOI : 10.1016/j.biomaterials.2004.02.013
Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography???tandem mass spectrometry, Journal of Chromatography A, vol.1021, issue.1-2, pp.133-144, 2003. ,
DOI : 10.1016/j.chroma.2003.08.089
In situ forming microparticle system for controlled delivery of leuprolide acetate: Influence of the formulation and processing parameters, European Journal of Pharmaceutical Sciences, vol.27, issue.2-3, pp.143-149, 2006. ,
DOI : 10.1016/j.ejps.2005.09.002
Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems, Journal of Controlled Release, vol.110, issue.2, pp.266-272, 2006. ,
DOI : 10.1016/j.jconrel.2005.10.005
Design of controlled-release formulation for ivermectin using silicone, International Journal of Pharmaceutics, vol.261, issue.1-2, pp.9-19, 2003. ,
DOI : 10.1016/S0378-5173(03)00293-X
Control of Boophilus annulatus (Acari: Ixodidae) on Cattle Using Injectable Microspheres Containing Ivermectin, Journal of Economic Entomology, vol.92, issue.5, pp.1142-1146, 1999. ,
DOI : 10.1093/jee/92.5.1142
Delivery of Ivermectin by Injectable Microspheres, Journal of Economic Entomology, vol.91, issue.3, pp.655-659, 1998. ,
DOI : 10.1093/jee/91.3.655
Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.3, pp.375-380, 2010. ,
DOI : 10.1016/j.ejpb.2010.04.004
Pharmaceutical challenges in veterinary product development, Advanced Drug Delivery Reviews, vol.54, issue.6, 2002. ,
DOI : 10.1016/S0169-409X(02)00074-1
The influence of solvent composition on the specific viscosities of polymer solutions, Journal of Colloid Science, vol.2, issue.1, pp.99-114, 1947. ,
DOI : 10.1016/0095-8522(47)90013-5
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems, Vaccine, vol.12, issue.4, pp.299-306, 1994. ,
DOI : 10.1016/0264-410X(94)90092-2
A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-420, 1995. ,
DOI : 10.1023/A:1016212804288
Biodegradation and biocompatibility of PLA and PLGA microspheres, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.5-24, 1997. ,
DOI : 10.1016/S0169-409X(97)00048-3
Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems, Advanced Drug Delivery Reviews, vol.58, issue.12-13, pp.1274-1325, 2006. ,
DOI : 10.1016/j.addr.2006.09.007
Total Parenteral Nutrition with Short- and Long-Chain Triglycerides: Triacetin Improves Nitrogen Balance in Rats, The Journal of Nutrition, vol.122, issue.9, pp.1823-1829, 1992. ,
DOI : 10.1093/jn/122.9.1823
Handbook of solubility parameters and other cohesion parameters, 1991. ,
Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research, vol.4, issue.Suppl 1, pp.244-249, 2006. ,
DOI : 10.1248/bpb1978.4.879
Handbook of biodegradable polymers, Rapra Technology, p.540, 2005. ,
In vitro evaluation of Poly(d,l-lactide-co-glycolide) polymer-based implants containing the ??-melanocyte stimulating hormone analog, Melanotan-I, Journal of Controlled Release, vol.45, issue.1, pp.49-55, 1997. ,
DOI : 10.1016/S0168-3659(96)01544-1
Plasticizing effect of water on poly(lactide-co-glycolide) Metabolism of triacetin-derived acetate in dogs, Journal of Controlled Release American Journal of Clinical Nutrition, vol.1089, issue.58, pp.908-911, 1993. ,
Preparation of Biodegradable Poly(??)lactide Microparticles Using a Spray-Drying Technique, Journal of Pharmacy and Pharmacology, vol.63, issue.11, pp.754-757, 1988. ,
DOI : 10.1002/jps.2600630325
Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen, Journal of Controlled Release, vol.10, issue.2, pp.167-175, 1989. ,
DOI : 10.1016/0168-3659(89)90059-X
Evaluation of Biodegradable Poly(lactide) Pellets Prepared by Direct Compression, Journal of Pharmaceutical Sciences, vol.78, issue.10, pp.819-822, 1989. ,
DOI : 10.1002/jps.2600781008
The preparation and evaluation of drug-containing poly(dllactide ) microspheres formed by the solvent evaporation method, Pharmaceutical Research, vol.04, issue.6, pp.465-471, 1987. ,
DOI : 10.1023/A:1016419303727
Solvent selection in the preparation of poly, 1988. ,
Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems, Journal of Controlled Release, vol.21, issue.1-3, pp.129-138, 1992. ,
DOI : 10.1016/0168-3659(92)90014-I
Preparation and Characterization of 5-Fluorouracil-loaded Microparticles as Biodegradable Anticancer Drug Carriers, Journal of Pharmacy and Pharmacology, vol.7, issue.2, pp.108-114, 1995. ,
DOI : 10.1016/0168-3659(88)90054-5
Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery, International Journal of Pharmaceutics, vol.116, issue.1, pp.1-9, 1995. ,
DOI : 10.1016/0378-5173(94)00324-X
Polylactic and polyglicolic acids as drug delivery carriers, 2000. ,
Handbook of Pharmaceutical Controlled Release Technology, pp.99-130 ,
Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.62, issue.3, pp.333-344, 1999. ,
DOI : 10.1016/S0168-3659(99)00159-5
Alza Corporation. Gel composition and methods, US Patent 6, 2000. ,
Assuring quality and performance of sustained and controlled release parenterals, European Journal of Pharmaceutical Sciences, vol.21, issue.5, pp.1761-1768, 2002. ,
DOI : 10.1016/j.ejps.2004.03.001
Why degradable polymers undergo surface erosion or bulk erosion, Biomaterials, vol.23, issue.21, pp.4221-4231, 2002. ,
DOI : 10.1016/S0142-9612(02)00170-9
The utility of cyclodextrins for enhancing oral bioavailability, Journal of Controlled Release, vol.123, issue.2, pp.78-99, 2007. ,
DOI : 10.1016/j.jconrel.2007.07.018
The formation and characterization of hydrocortisone-loaded poly((??)-lactide) microspheres, Journal of Pharmacy and Pharmacology, vol.10, issue.4, pp.249-253, 1986. ,
DOI : 10.1002/pol.1972.160100706
Swelling of and Drug Release from Monoglyceride-Based Drug Delivery Systems, Journal of Pharmaceutical Sciences, vol.86, issue.6, pp.747-752, 1997. ,
DOI : 10.1021/js960256w
Alzamer Depot bioerodible polymer technology, 2008. ,
Liquid polymeric compositions for controlled release of bioactive substances. WO patent 9947073, 1999. ,
Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system, International Journal of Pharmaceutics, vol.342, issue.1-2, pp.72-77, 2007. ,
DOI : 10.1016/j.ijpharm.2007.04.034
Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs, American Journal of Veterinary Research, vol.65, issue.6, pp.752-757, 2004. ,
DOI : 10.2460/ajvr.2004.65.752
Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: Effect of emulsifier on the microsphere characteristics and release kinetics, European Journal of Pharmaceutics and Biopharmaceutics, vol.42, pp.42-48, 1996. ,
Nano- and microparticles for the delivery of polypeptides and proteins, Advanced Drug Delivery Reviews, vol.10, issue.2-3, pp.141-162, 1993. ,
DOI : 10.1016/0169-409X(93)90046-7
[8] Poly(lactide-co-glycolide) microcapsules for controlled release of steroids, Methods in Enzymology, vol.112, pp.101-116, 1985. ,
DOI : 10.1016/S0076-6879(85)12010-0
Biodegradable microparticles for the controlled delivery of oligonucleotides, International Journal of Pharmaceutics, vol.242, issue.1-2, pp.225-228, 2002. ,
DOI : 10.1016/S0378-5173(02)00162-X
Stability of poly(d,l-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems, Journal of Controlled Release, vol.115, issue.2, pp.158-167, 2006. ,
DOI : 10.1016/j.jconrel.2006.07.013
Thermoanalysis of microspheres, Thermochimica Acta, vol.248, pp.259-269, 1995. ,
DOI : 10.1016/0040-6031(94)01947-F
Biodegradable in-situ forming implants and methods of producing the same, US Patent, vol.4, p.938763, 1990. ,
Biodegradable in-situ forming implants and methods of producing the same, p.201, 1994. ,
Biodegradable in-situ forming implants and methods of producing the same, p.739176, 1998. ,
Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants, p.716, 1997. ,
Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials, vol.21, issue.16, pp.1659-1668, 2000. ,
DOI : 10.1016/S0142-9612(00)00040-5
Qualitative predictions of solubilization of highly hydrophobic drugs in block copolymer micelles, 2005. ,
Composition and method for forming biodegradable implants in situ and uses of these implants. WO Patent 9742987, 1997. ,
Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins, Journal of Biomedical Materials Research, vol.22, issue.3, pp.388-396, 2000. ,
DOI : 10.1002/aic.690180523
Robust and prolonged gene expression from injectable polymeric implants, Gene Therapy, vol.6, issue.18, pp.1230-1237, 2002. ,
DOI : 10.1038/sj.gt.3300929
URL : http://www.nature.com/gt/journal/v9/n18/pdf/3301786a.pdf
Delivery of soluble tumor necrosis factor receptor from insitu forming PLGA implants: In vivo, Pharmaceutical Research, vol.17, issue.12, pp.1546-1550, 2000. ,
DOI : 10.1023/A:1007621512647
Phase behaviour of the lidocaine-monoolein-water system, International Journal of Pharmaceutics, vol.79, issue.1-3, pp.113-122, 1992. ,
DOI : 10.1016/0378-5173(92)90102-8
Factors influencing release of salbutamol sulphate from poly(lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique, International Journal of Pharmaceutics, vol.137, issue.1, pp.57-66, 1996. ,
DOI : 10.1016/0378-5173(96)04454-7
PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release, European Journal of Pharmaceutical Sciences, vol.15, issue.4, pp.355-366, 2002. ,
DOI : 10.1016/S0928-0987(02)00023-4
The use of silicone rubber as a carrier for prolonged drug therapy, Journal of Surgical Research, vol.4, issue.3, pp.139-142, 1964. ,
DOI : 10.1016/S0022-4804(64)80040-8
Silicone Rubber: A New Diffusion Property Useful for General Anesthesia, Science, vol.154, issue.3745, pp.148-149, 1966. ,
DOI : 10.1126/science.154.3745.148
Risk minimization action plan (RiskMAP) for: PROHEART® 6 (moxidectin), 2008. ,
) Doc. [En ligne]-Adresse URL : http://www.fda.gov, 2010. ,
Guardian SR. Fort Dodge Animal Health, 2010. ,
Controlled release from bioerodible polymers: effect of drug type and polymer composition, Journal of Controlled Release, vol.102, issue.2, pp.333-344, 2005. ,
DOI : 10.1016/j.jconrel.2004.10.019
Polymer microspheres for controlled drug release, International Journal of Pharmaceutics, vol.282, issue.1-2, pp.1-18, 2004. ,
DOI : 10.1016/j.ijpharm.2004.04.013
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology, Journal of Controlled Release, vol.102, issue.2, pp.313-332, 2005. ,
DOI : 10.1016/j.jconrel.2004.10.015
Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres, Journal of Controlled Release, vol.69, issue.1, pp.197-207, 2000. ,
DOI : 10.1016/S0168-3659(00)00299-6
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres, Pharmaceutical Research, vol.17, issue.1, pp.100-106, 2000. ,
DOI : 10.1023/A:1007582911958
Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development, Biotechnology and Bioengineering, vol.536, issue.1??????3, pp.409-420, 2010. ,
DOI : 10.1248/bpb1978.6.124
Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: In vitro evaluation, Pharmaceutical Research, vol.12, issue.6, pp.857-863, 1995. ,
DOI : 10.1023/A:1016209020160
Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: In vivo evaluation, Pharmaceutical Research, vol.12, issue.6, pp.864-868, 1995. ,
DOI : 10.1023/A:1016261004230
Ivermectin 20 years on: maturation of a wonder drug, Trends in Parasitology, vol.21, issue.11, pp.530-532, 2005. ,
DOI : 10.1016/j.pt.2005.08.014
PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery, Polymer Bulletin, vol.59, issue.5, pp.637-646, 2007. ,
DOI : 10.1007/s00289-007-0807-4
Safety Profile of Moxidectin (ProHeart 6) and Two Oral Heartworm Preventives in Dogs, International Journal of Applied Research in Veterinary Medicine, vol.3, issue.2, 2005. ,
Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs, Veterinary Parasitology, vol.135, issue.3-4, 2006. ,
DOI : 10.1016/j.vetpar.2005.10.002
The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009. ,
DOI : 10.1016/j.tvjl.2007.07.011
Mechanisms of polymer degradation and erosion, Biomaterials, vol.17, issue.2, pp.103-114, 1996. ,
DOI : 10.1016/0142-9612(96)85755-3
Polymer Bulk Erosion, Macromolecules, vol.30, issue.9, pp.2598-2604, 1997. ,
DOI : 10.1021/ma961627y
Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.58, issue.2, pp.233-245, 1999. ,
DOI : 10.1016/S0168-3659(98)00158-8
Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence, Biomaterials, vol.16, issue.4, pp.305-311, 1995. ,
DOI : 10.1016/0142-9612(95)93258-F
The three dimensional solubility parameter-key to paint component affinities: II and III, Journal of paint technology, vol.39, pp.505-514, 1967. ,
Polymer additives and solubility parameters, Progress in Organic Coatings, vol.51, issue.2, pp.109-112, 2004. ,
DOI : 10.1016/j.porgcoat.2004.05.003
Hansen solubility parameters: A user's handbook, 2007. ,
DOI : 10.1201/9781420049312
Biodegradable injectable in situ forming drug delivery systems, Journal of Controlled Release, vol.80, issue.1-3, 2002. ,
DOI : 10.1016/S0168-3659(02)00008-1
Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas, Veterinary and Comparative Oncology, vol.14, issue.2, pp.122-129, 2009. ,
DOI : 10.1111/j.1939-1676.2000.tb02279.x
Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds, Veterinary Parasitology, vol.72, issue.3-4, pp.367-382, 1997. ,
DOI : 10.1016/S0304-4017(97)00106-4
The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method, Journal of Controlled Release, vol.36, issue.1-2, pp.63-71, 1995. ,
DOI : 10.1016/0168-3659(95)00051-9
Lipidic nanocapsules: preparation process and use as Drug Delivery Systems, 2000. ,
Regular solutions, 1962. ,
The origins and evolution of ???controlled??? drug delivery systems, Journal of Controlled Release, vol.132, issue.3, pp.153-163, 2008. ,
DOI : 10.1016/j.jconrel.2008.08.012
The preparation and evaluation of poly(??-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug, Journal of Controlled Release, vol.65, issue.3, pp.429-438, 2000. ,
DOI : 10.1016/S0168-3659(99)00253-9
Le traitement des ectoparasitoses des rongers et lagomorphes par les avermectines, Thèse pour le Diplôme, 2003. ,
Poly(Lactic Acid) and Copolyesters Handbook of biodegradable polymers. United Kingdom. Rapra Technology, pp.287-301, 2005. ,
The Viscosity of Dilute Solutions of Long-Chain Molecules. IV. Dependence on Concentration, Journal of the American Chemical Society, vol.64, issue.11, pp.2716-2718, 1942. ,
DOI : 10.1021/ja01263a056
Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009. ,
DOI : 10.1016/j.ijpharm.2009.04.026
Dissertation: In vitro and in vivo properties of injectable biodegradable in situ forming microparticle systmes, Faculty of Biology, 2002. ,
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, vol.21, issue.23, pp.2475-2490, 2000. ,
DOI : 10.1016/S0142-9612(00)00115-0
Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables, European Journal of Pharmaceutics and Biopharmaceutics, vol.50, issue.2, pp.257-262, 2000. ,
DOI : 10.1016/S0939-6411(00)00062-X
Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles, Journal of Microencapsulation, vol.19, issue.2, pp.117-128, 2007. ,
DOI : 10.1023/A:1015168301339
Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio, Journal of Controlled Release, vol.139, issue.1, pp.8-14, 2009. ,
DOI : 10.1016/j.jconrel.2009.05.029
Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(?,?-lactide-co-glycolide) microspheres, Journal of Controlled Release, vol.79, issue.1-3, pp.137-145, 2002. ,
DOI : 10.1016/S0168-3659(01)00533-8
Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres, Vaccine, vol.19, issue.9-10, pp.1047-1054, 2000. ,
DOI : 10.1016/S0264-410X(00)00343-1
Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication, International Journal of Pharmaceutics, vol.364, issue.1, pp.45-53, 2008. ,
DOI : 10.1016/j.ijpharm.2008.08.015
Parenteral depot-systems on the basis of biodegradable polyesters, Journal of Controlled Release, vol.16, issue.1-2, pp.27-42, 1991. ,
DOI : 10.1016/0168-3659(91)90028-C
Parenteral depot systems and their application in the pharmaceutical industry, 2006. ,
Methods and industrial application. Boca raton, pp.113-122 ,
How porosity and size affect the drug release mechanisms from PLGA-based microparticles, International Journal of Pharmaceutics, vol.314, issue.2, pp.198-206, 2006. ,
DOI : 10.1016/j.ijpharm.2005.07.031
PLGA-based drug delivery systems: Importance of the type of drug and device geometry, International Journal of Pharmaceutics, vol.354, issue.1-2, pp.95-103, 2008. ,
DOI : 10.1016/j.ijpharm.2007.10.030
Development of an in situ forming PLGA drug delivery system, European Journal of Pharmaceutical Sciences, vol.35, issue.4, pp.283-292, 2008. ,
DOI : 10.1016/j.ejps.2008.07.007
A novel in situ forming drug delivery system for controlled parenteral drug delivery, International Journal of Pharmaceutics, vol.332, issue.1-2, pp.107-114, 2007. ,
DOI : 10.1016/j.ijpharm.2006.09.033
Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008. ,
DOI : 10.1016/j.ejps.2008.03.004
How to make hypericin water-soluble, Pharmazie, vol.63, pp.263-269, 2008. ,
Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route, Journal of Microencapsulation, vol.30, issue.4, pp.449-460, 1993. ,
DOI : 10.1248/cpb.30.3719
Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins, Journal of Controlled Release, vol.33, issue.1, pp.189-195, 1995. ,
DOI : 10.1016/0168-3659(94)00083-7
Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces, Chemical Research in Toxicology, vol.22, issue.8, pp.1376-1385, 2009. ,
DOI : 10.1021/tx900086v
In vitro peptide release from liquid crystalline buccal delivery systems, International Journal of Pharmaceutics, vol.195, issue.1-2, pp.29-33, 2000. ,
DOI : 10.1016/S0378-5173(99)00356-7
Kinetics of drug release from polylactic acid???hydrocortisone microcapsules, Journal of Microencapsulation, vol.64, issue.3, pp.171-179, 1986. ,
DOI : 10.1002/jps.2600640124
A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading, Journal of Microencapsulation, vol.23, issue.2, pp.147-157, 1988. ,
DOI : 10.1016/0020-7292(85)90106-7
Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.33-43, 2007. ,
DOI : 10.1016/j.ijpharm.2007.05.054
URL : https://hal.archives-ouvertes.fr/hal-00180715
Controlled release of bioactive agents from lactide/glycolide polymers, 1990. ,
Biodegradable polymers as drug delivery systems ,
Microencapsulation by solvent evaporation: State of the art for process engineering approaches, International Journal of Pharmaceutics, vol.363, issue.1-2, pp.26-39, 2008. ,
DOI : 10.1016/j.ijpharm.2008.07.018
Processing technologies for poly(lactic acid), Progress in Polymer Science, vol.33, issue.8, pp.820-852, 2008. ,
DOI : 10.1016/j.progpolymsci.2008.05.004
Temperature-dependent micellization in aqueous block copolymer solutions, Macromolecules, vol.25, issue.20, pp.5434-5439, 1992. ,
DOI : 10.1021/ma00046a048
Microspheres of corn protein, zein, for an ivermectin drug delivery system, Biomaterials, vol.26, issue.1, pp.109-115, 2005. ,
DOI : 10.1016/j.biomaterials.2004.02.013
Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography???tandem mass spectrometry, Journal of Chromatography A, vol.1021, issue.1-2, pp.133-144, 2003. ,
DOI : 10.1016/j.chroma.2003.08.089
In situ forming microparticle system for controlled delivery of leuprolide acetate: Influence of the formulation and processing parameters, European Journal of Pharmaceutical Sciences, vol.27, issue.2-3, pp.143-149, 2006. ,
DOI : 10.1016/j.ejps.2005.09.002
Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems, Journal of Controlled Release, vol.110, issue.2, pp.266-272, 2006. ,
DOI : 10.1016/j.jconrel.2005.10.005
Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles, International Journal of Pharmaceutics, vol.324, issue.2, pp.168-175, 2006. ,
DOI : 10.1016/j.ijpharm.2006.06.004
Medication vehicles made of solid lipid particles (solid lipid Nanospheres SLN) EP0000605497, 1991. ,
Design of controlled-release formulation for ivermectin using silicone, International Journal of Pharmaceutics, vol.261, issue.1-2, pp.9-19, 2003. ,
DOI : 10.1016/S0378-5173(03)00293-X
Applying the biopharmaceutics classification system to veterinary pharmaceutical products Part II. Physiological considerations, Advanced Drug Delivery Reviews, vol.54, issue.6, pp.825-850, 2002. ,
DOI : 10.1016/S0169-409X(02)00071-6
Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products Part I: Biopharmaceutics and formulation considerations, Advanced Drug Delivery Reviews, vol.54, issue.6, pp.805-824, 2002. ,
DOI : 10.1016/S0169-409X(02)00070-4
Sustained-release injectables formed in situ and their potential use for veterinary products, Journal of Controlled Release, vol.85, issue.1-3, pp.1-15, 2002. ,
DOI : 10.1016/S0168-3659(02)00266-3
Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin sulfate in films prepared from high and low molecular weight poly (DL-lactic acids), Journal of Controlled Release, vol.25, issue.1-2, pp.43-49, 1993. ,
DOI : 10.1016/0168-3659(93)90093-K
Preparation of microspheres by the solvent evaporation technique, Advanced Drug Delivery Reviews, vol.28, pp.25-42, 1997. ,
Prevention of experimentally induced heartworm (Dirofilaria immitis) infections in dogs and cats with a single topical application of selamectin, Veterinary Parasitology, vol.91, issue.3-4, pp.259-268, 2000. ,
DOI : 10.1016/S0304-4017(00)00297-1
Creating a Global leader in Animal Health. Call conference 09 march 2010, ) Doc. [En ligne]-Adresse URL, 2010. ,
Control of Boophilus annulatus (Acari: Ixodidae) on Cattle Using Injectable Microspheres Containing Ivermectin, Journal of Economic Entomology, vol.92, issue.5, pp.1142-1146, 1999. ,
DOI : 10.1093/jee/92.5.1142
Delivery of Ivermectin by Injectable Microspheres, Journal of Economic Entomology, vol.91, issue.3, pp.655-659, 1998. ,
DOI : 10.1093/jee/91.3.655
Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios, Journal of Biomedical Materials Research, vol.5, issue.5, pp.711-719, 1977. ,
DOI : 10.1002/jbm.820110507
Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives, Journal of Controlled Release, vol.125, issue.3, pp.193-209, 2008. ,
DOI : 10.1016/j.jconrel.2007.09.013
Microencapsulation by coacervation of poly(lactide-co-glycolide) IV. Effect of the processing parameters on coacervation and encapsulation, Journal of Controlled Release, vol.35, issue.2-3, pp.117-125, 1995. ,
DOI : 10.1016/0168-3659(95)00026-5
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.43-70, 1997. ,
DOI : 10.1016/S0169-409X(97)00050-1
Prolonged release microcapsules and their production, US patent, vol.4652, p.441, 1987. ,
Sustained delivery of human growth hormone from a novel gel system: SABERTM, Biomaterials, vol.23, issue.22, pp.4353-4358, 2002. ,
DOI : 10.1016/S0142-9612(02)00174-6
Ivermectin: 25 years and still going strong, International Journal of Antimicrobial Agents, vol.31, issue.2, pp.91-98, 2008. ,
DOI : 10.1016/j.ijantimicag.2007.08.023
In situ forming parenteral drug delivery systems: an overview, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.445-455, 2004. ,
DOI : 10.1016/j.ejpb.2004.03.003
Lonidamine Solid Dispersions: In Vitro and In Vivo Evaluation, Drug Development and Industrial Pharmacy, vol.61, issue.10, pp.1241-1250, 2002. ,
DOI : 10.3109/03639049309062990
A novel interpretation of concentration dependence of viscosity of dilute polymer solution, Chinese Journal of Polymer Science, vol.18, pp.57-67, 2000. ,
Biodegradable Polymers for Microencapsulation of Drugs, Molecules, vol.15, issue.1, pp.146-161, 2005. ,
DOI : 10.1016/j.jconrel.2003.12.020
Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition, Biomaterials, vol.16, issue.15, pp.1123-1130, 1995. ,
DOI : 10.1016/0142-9612(95)93575-X
Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (??-caprolactone), and their copolymers in vivo, Biomaterials, vol.2, issue.4, pp.215-220, 1981. ,
DOI : 10.1016/0142-9612(81)90060-0
Manipulation of the rate of hydrolysis of polymer-drag conjugates: the degree of hydration, Journal of Controlled Release, vol.33, issue.3, pp.397-403, 1995. ,
DOI : 10.1016/0168-3659(94)00098-F
Formulation of poorly water-soluble drugs for oral administration, 2006. ,
Modified release drug delivery in veterinary medicine, Drug Discovery Today, vol.7, issue.15, pp.823-829, 2002. ,
DOI : 10.1016/S1359-6446(02)02362-0
Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles, Powder Technology, vol.171, issue.1, pp.7-14, 2007. ,
DOI : 10.1016/j.powtec.2006.09.007
Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide, International Journal of Pharmaceutics, vol.194, issue.2, pp.181-191, 2000. ,
DOI : 10.1016/S0378-5173(99)00371-3
MICROENCAPSULATION BY SPRAY DRYING, Drying Technology, vol.1, issue.6, pp.1195-1236, 1998. ,
DOI : 10.1016/0168-3659(94)90227-5
Microparticle formation and its mechanism in single and double emulsion solvent evaporation, Journal of Controlled Release, vol.99, issue.2, pp.271-280, 2004. ,
DOI : 10.1016/j.jconrel.2004.07.007
Formulation and technology aspects of conrolled drug delivery in animals, Pharmaceutical Science & Technology Today, vol.3, issue.7, pp.222-231, 2000. ,
DOI : 10.1016/S1461-5347(00)00276-5
Handbook of Pharmaceutical Excipients, 2006. ,
Improving the solubility of ampelopsin by solid dispersions and inclusion complexes, Journal of Pharmaceutical and Biomedical Analysis, vol.38, issue.3, pp.457-464, 2005. ,
DOI : 10.1016/j.jpba.2005.01.030
In situ-forming hydrogels???review of temperature-sensitive systems, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.409-426, 2004. ,
DOI : 10.1016/j.ejpb.2004.03.019
Injectability of biodegradable in situ forming microparticle systems (ISM), European Journal of Pharmaceutical Sciences, vol.36, issue.4-5, pp.524-531, 2009. ,
DOI : 10.1016/j.ejps.2008.12.003
Myotoxicity studies of O/W-in situ forming microparticle systems, European Journal of Pharmaceutics and Biopharmaceutics, vol.69, issue.1, pp.126-133, 2008. ,
DOI : 10.1016/j.ejpb.2007.10.009
Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres, International Journal of Pharmaceutics, vol.98, issue.1-3, pp.157-164, 1993. ,
DOI : 10.1016/0378-5173(93)90052-H
Eligard: leuprolide acetate in a novel sustained-release delivery system, Urology, vol.61, issue.2, pp.25-31, 2003. ,
DOI : 10.1016/S0090-4295(02)02396-8
Biodegradable hollow fibres for the controlled release of drugs, Biomaterials, vol.9, issue.1, pp.116-120, 1988. ,
DOI : 10.1016/0142-9612(88)90082-8
Partial solubility parameters of poly(d,l-lactide-co-glycolide), International Journal of Pharmaceutics, vol.286, issue.1-2, pp.19-26, 2004. ,
DOI : 10.1016/j.ijpharm.2004.07.034
Cubic phase gels as drug delivery systems, Advanced Drug Delivery Reviews, vol.47, issue.2-3, 2001. ,
DOI : 10.1016/S0169-409X(01)00108-9
A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) copolymers, Journal of Controlled Release, vol.27, issue.2, pp.139-147, 1993. ,
DOI : 10.1016/0168-3659(93)90217-S
Poly (glycolic acid-co-dl-lactic acid): diffusion or degradation controlled drug delivery?, Journal of Controlled Release, vol.18, issue.3, pp.261-270, 1992. ,
DOI : 10.1016/0168-3659(92)90171-M
Physico-chemical characterization of a polymeric injectable implant delivery system, Journal of Controlled Release, vol.33, issue.2, pp.237-243, 1995. ,
DOI : 10.1016/0168-3659(94)00097-E
pH-dependent equilibrium swelling properties of hydrophobic polyelectrolyte copolymer gels, Macromolecules, vol.21, issue.11, pp.3254-3259, 1988. ,
DOI : 10.1021/ma00189a021
How Autocatalysis Accelerates Drug Release from PLGA-Based Microparticles:?? A Quantitative Treatment, Biomacromolecules, vol.6, issue.4, pp.2312-2319, 2005. ,
DOI : 10.1021/bm050228k
Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration, International Journal of Pharmaceutics, vol.30, issue.2-3, pp.215-220, 1986. ,
DOI : 10.1016/0378-5173(86)90081-5
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes, Handbook of Experimental Pharmacology, pp.115-141, 2010. ,
DOI : 10.1007/978-3-642-00477-3_4
Dental Drug-Delivery Devices: Local and Sustained-Release Applications, Critical Reviews?? in Therapeutic Drug Carrier Systems, vol.16, issue.5, pp.425-459, 1999. ,
DOI : 10.1615/CritRevTherDrugCarrierSyst.v16.i5.10
Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004. ,
DOI : 10.1023/B:PHAM.0000016235.32639.23
Microencapsulation using Coacervation/Phase separation: An overview of the technique and applications Handbook of Pharmaceutical Controlled Release Technology, pp.301-328, 2000. ,
Issues and challenges in developing long-acting veterinary antibiotic formulations, Advanced Drug Delivery Reviews, vol.56, issue.10, pp.1481-1496, 2004. ,
DOI : 10.1016/j.addr.2004.02.009
Manufacture of porous polymer nerve conduits by a novel low-pressure injection molding process, Biomaterials, vol.24, issue.5, pp.819-830, 2003. ,
DOI : 10.1016/S0142-9612(02)00409-X
Microencapsulation and Dissolution Properties of a Neuroleptic in a Biodegradable Polymer, Poly(d,l-lactide), Journal of Pharmaceutical Sciences, vol.74, issue.1, pp.21-24, 1985. ,
DOI : 10.1002/jps.2600740106
Polymer solutions: An introduction to physical properties, 2002. ,
DOI : 10.1002/0471224510
Drug Microencapsulation by PLA/PLGA Coacervation in the Light of Thermodynamics. 2. Parameters Determining Microsphere Formation, Journal of Pharmaceutical Sciences, vol.87, issue.3, 1998. ,
DOI : 10.1021/js970048j
Biodegradable controlled-release parenteral systems, Pharmaceutical Technology, vol.8, 1984. ,
Southern Biosystems, Inc.High viscosity liquid controlled delivery system, US Patent, vol.5747, p.58, 1998. ,
Polymeric Systems for Controlled Drug Release, Chemical Reviews, vol.99, issue.11, pp.3181-3198, 1999. ,
DOI : 10.1021/cr940351u
Formation of porous membranes for drug delivery systems, Journal of Controlled Release, vol.24, pp.61-78, 1993. ,
Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles, Journal of Liposome Research, vol.45, issue.1, pp.115-123, 2010. ,
DOI : 10.1016/S0939-6411(97)00150-1
Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide, Cancer Research, vol.52, pp.6653-6656, 1992. ,
The influence of terminal gamma-sterilization on captopril containing poly(d,l-lactide-co-glycolide) microspheres, Journal of Controlled Release, vol.31, issue.3, pp.293-304, 1994. ,
DOI : 10.1016/0168-3659(94)90012-4
Drug release from injectable depots: two different in vitro mechanisms, Journal of Controlled Release, vol.99, issue.2, pp.207-216, 2004. ,
DOI : 10.1016/j.jconrel.2004.06.021
Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems, Advanced Drug Delivery Reviews, vol.56, issue.10, pp.1453-1466, 2004. ,
DOI : 10.1016/j.addr.2004.02.008
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, International Journal of Pharmaceutics, vol.364, issue.2, pp.298-327, 2008. ,
DOI : 10.1016/j.ijpharm.2008.04.042
Handbook of Pharmaceutical Controlled Release Technology, 2000. ,
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing, Journal of Controlled Release, vol.51, issue.2-3, pp.327-341, 1998. ,
DOI : 10.1016/S0168-3659(97)00188-0
The Design of Scaffolds for Use in Tissue Engineering. Part I. Traditional Factors, Tissue Engineering, vol.7, issue.6, pp.679-689, 2001. ,
DOI : 10.1089/107632701753337645
Controlled release of testosterone and estradiol-17 ?? from biodegradable cylinders, Journal of Controlled Release, vol.29, issue.1-2, pp.157-161, 1994. ,
DOI : 10.1016/0168-3659(94)90131-7
Evaluation of in vivo???in vitro release of dexamethasone from PLGA microspheres, Journal of Controlled Release, vol.127, issue.2, pp.137-145, 2008. ,
DOI : 10.1016/j.jconrel.2008.01.004